Brokerages Set Enhabit, Inc. (NYSE:EHAB) Target Price at $8.75

Shares of Enhabit, Inc. (NYSE:EHAB) have received a consensus rating of “Hold” from the six research firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $8.75.

EHAB has been the topic of several analyst reports. Jefferies Financial Group raised shares of Enhabit from a “hold” rating to a “buy” rating and boosted their price target for the company from $8.25 to $9.50 in a report on Monday, December 9th. Leerink Partners reissued a “market perform” rating and issued a $8.00 price target (down previously from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th.

Insider Activity

In other Enhabit news, Director Jeffrey Bolton bought 4,000 shares of the stock in a transaction dated Thursday, December 12th. The stock was bought at an average cost of $8.69 per share, for a total transaction of $34,760.00. Following the completion of the purchase, the director now owns 98,144 shares in the company, valued at $852,871.36. This represents a 4.25 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stuart M. Mcguigan purchased 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The stock was acquired at an average cost of $8.81 per share, with a total value of $132,150.00. Following the completion of the acquisition, the director now directly owns 46,810 shares of the company’s stock, valued at $412,396.10. The trade was a 47.15 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.90% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Enhabit

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. FMR LLC raised its position in shares of Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after acquiring an additional 1,967 shares during the last quarter. Quarry LP increased its position in Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after purchasing an additional 2,621 shares during the period. Gladius Capital Management LP raised its holdings in Enhabit by 78.2% during the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock worth $49,000 after purchasing an additional 2,747 shares during the last quarter. Stoneridge Investment Partners LLC acquired a new position in Enhabit during the 3rd quarter valued at about $81,000. Finally, AQR Capital Management LLC bought a new position in shares of Enhabit in the 2nd quarter valued at about $94,000.

Enhabit Trading Up 0.7 %

Shares of EHAB opened at $8.50 on Friday. The stock’s 50-day moving average price is $8.02 and its 200 day moving average price is $8.03. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $427.16 million, a price-to-earnings ratio of -3.66 and a beta of 1.83. Enhabit has a 12-month low of $6.85 and a 12-month high of $11.74.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The firm had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same quarter in the prior year, the firm posted $0.03 earnings per share. As a group, research analysts predict that Enhabit will post 0.22 earnings per share for the current year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.